Results 111 to 120 of about 269,013 (347)
Antidepressants in bipolar depression: an enduring controversy
International Journal of Bipolar Disorders, 2018 The proper place and the optimal use of antidepressants in treating bipolar depression continues to be an area of great interest and greater controversy with passionate opinions more common than good studies. Even the handful of meta-analyses in the area
Michael J. Gitlin
doaj +1 more source
The Paroxetine 352 Bipolar Study Revisited: Deconstruction of Corporate and Academic Misconduct [PDF]
, 2019 Medical ghostwriting is the practice in which pharmaceutical companies engage an outside writer to draft a manuscript submitted for publication in the names of “honorary authors,” typically academic key opinion leaders.
Amsterdam, Jay D., McHenry, Leemon
core
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, EarlyView.ABSTRACT Ernst Rüdin, an important and controversial figure in the history of psychiatric genetics, published only one major empirical study on siblings of dementia praecox (DP) probands in 1916. He conducted a parallel study of siblings of probands with manic‐depressive insanity (MDI), but the resulting monograph, written in the early 1920s, was left ...
Kenneth S. Kendler, Astrid Klee
wiley +1 more source
Is bipolar mixed depression associated with a good response to psychotropic augmentation?
European PsychiatryIs bipolar mixed depression associated with a good response to psychotropic augmentation? Zoltán Rihmer Department of Psychiatry and Psychotherapy, Semmelweis University, Budapest and at the National Institute of Mental Helath, Neurology and Neurosurgery,
Z. Rihmer
doaj +1 more source
Psychiatry and Clinical Psychopharmacology, 2021 The evidence-base for the psychopharmacological treatment of psychiatric disorders comes almost entirely from studies in patients with syndromes defined by the criteria in the Diagnostic and Statistical Manual of Psychiatric Disorders (DSM).
David Osser
doaj
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, EarlyView.ABSTRACT Polygenic risk scores (PRS) estimate individuals' genetic risk for developing multifactorial conditions. Recent genome‐wide association studies have enabled development of psychiatric PRS, which hold potential to streamline diagnosis and treatment of psychiatric conditions.
Lauren A. Ginn +11 more
wiley +1 more source
Pharmacological Treatment of Bipolar Depression: What are the Current and Emerging Options?
Neuropsychiatric Disease and Treatment, 2020 Nefize Yalin, Allan H Young Centre for Affective Disorders, Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, London, UKCorrespondence: Allan H YoungCentre for Affective Disorders, Department of Psychological ...
Yalin N, Young AH
doaj
Cognition and functioning in bipolar depression
Brazilian Journal of Psychiatry, 2016 Objectives: Depressive symptoms are associated with worse outcomes in patients with bipolar disorder (BD). However, scarce data are available regarding neurocognitive profiles across different areas of functioning among BD patients with moderate and ...
Natalia S. Kapczinski +10 more
doaj +1 more source
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, EarlyView.ABSTRACT Women with the FMR1 premutation (PM) are at increased risk for fragile X‐associated conditions (FXPAC), including cognitive and psychiatric features collectively termed fragile X‐associated neuropsychiatric disorders (FXAND). This study is the first to systematically investigate cognitive and psychiatric features in Italian female premutation ...
Federica Alice Maria Montanaro +5 more
wiley +1 more source